BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27644130)

  • 1. Familial Alzheimer's Disease Lymphocytes Respond Differently Than Sporadic Cells to Oxidative Stress: Upregulated p53-p21 Signaling Linked with Presenilin 1 Mutants.
    Wojsiat J; Laskowska-Kaszub K; Alquézar C; Białopiotrowicz E; Esteras N; Zdioruk M; Martin-Requero A; Wojda U
    Mol Neurobiol; 2017 Sep; 54(7):5683-5698. PubMed ID: 27644130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly pathogenic Alzheimer's disease presenilin 1 P117R mutation causes a specific increase in p53 and p21 protein levels and cell cycle dysregulation in human lymphocytes.
    Bialopiotrowicz E; Szybinska A; Kuzniewska B; Buizza L; Uberti D; Kuznicki J; Wojda U
    J Alzheimers Dis; 2012; 32(2):397-415. PubMed ID: 22810102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurons overexpressing mutant presenilin-1 are more sensitive to apoptosis induced by endoplasmic reticulum-Golgi stress.
    Terro F; Czech C; Esclaire F; Elyaman W; Yardin C; Baclet MC; Touchet N; Tremp G; Pradier L; Hugon J
    J Neurosci Res; 2002 Aug; 69(4):530-9. PubMed ID: 12210846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulation distinguishes lymphocytes from sporadic and familial Alzheimer's disease patients.
    Bialopiotrowicz E; Kuzniewska B; Kachamakova-Trojanowska N; Barcikowska M; Kuznicki J; Wojda U
    Neurobiol Aging; 2011 Dec; 32(12):2319.e13-26. PubMed ID: 20541838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thapsigargin affects presenilin-2 but not presenilin-1 regulation in SK-N-BE cells.
    Rivabene R; Visentin S; Piscopo P; De Nuccio C; Crestini A; Svetoni F; Rosa P; Confaloni A
    Exp Biol Med (Maywood); 2014 Feb; 239(2):213-24. PubMed ID: 24363250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presenilin 1 promotes trypsin-induced neuroprotection via the PAR2/ERK signaling pathway. Effects of presenilin 1 FAD mutations.
    Nikolakopoulou AM; Georgakopoulos A; Robakis NK
    Neurobiol Aging; 2016 Jun; 42():41-9. PubMed ID: 27143420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPβ fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications.
    Soto-Mercado V; Mendivil-Perez M; Velez-Pardo C; Lopera F; Jimenez-Del-Rio M
    PLoS One; 2020; 15(5):e0221669. PubMed ID: 32437347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of aging: sporadic, and genetic risk factors on vulnerability to apoptosis in Alzheimer's disease.
    Schindowski K; Kratzsch T; Peters J; Steiner B; Leutner S; Touchet N; Maurer K; Czech C; Pradier L; Frölich L; Müller WE; Eckert A
    Neuromolecular Med; 2003; 4(3):161-78. PubMed ID: 14716024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
    Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
    J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.
    Zatti G; Burgo A; Giacomello M; Barbiero L; Ghidoni R; Sinigaglia G; Florean C; Bagnoli S; Binetti G; Sorbi S; Pizzo P; Fasolato C
    Cell Calcium; 2006 Jun; 39(6):539-50. PubMed ID: 16620965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
    Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle-driven neuronal apoptosis specifically linked to amyloid peptide Abeta1-42 exposure is not exacerbated in a mouse model of presenilin-1 familial Alzheimer's disease.
    Malik B; Currais A; Soriano S
    J Neurochem; 2008 Jul; 106(2):912-6. PubMed ID: 18466334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer's Disease Patients.
    Dinkel F; Trujillo-Rodriguez D; Villegas A; Streffer J; Mercken M; Lopera F; Glatzel M; Sepulveda-Falla D
    Front Aging Neurosci; 2020; 12():220. PubMed ID: 32848702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal intracellular trafficking of high affinity nerve growth factor receptor, Trk, in stable transfectants expressing presenilin 1 protein.
    Hamano T; Mutoh T; Tabira T; Araki W; Kuriyama M; Mihara T; Yano S; Yamamoto H
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):70-6. PubMed ID: 15950763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive decline in patients with familial Alzheimer's disease associated with E280a presenilin-1 mutation: a longitudinal study.
    Rosselli MC; Ardila AC; Moreno SC; Standish VC; Arango-Lasprilla JC; Tirado VM; Ossa JM; Goate AM; Kosik KS; Lopera F
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):483-95. PubMed ID: 10923058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer's disease patients.
    Uberti D; Carsana T; Bernardi E; Rodella L; Grigolato P; Lanni C; Racchi M; Govoni S; Memo M
    J Cell Sci; 2002 Aug; 115(Pt 15):3131-8. PubMed ID: 12118068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease-linked presenilin 1 A246E mutation can be reversed with cAMP.
    Coffey EE; Beckel JM; Laties AM; Mitchell CH
    Neuroscience; 2014 Mar; 263():111-24. PubMed ID: 24418614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
    Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
    J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenilin-dependent expression of STIM proteins and dysregulation of capacitative Ca2+ entry in familial Alzheimer's disease.
    Bojarski L; Pomorski P; Szybinska A; Drab M; Skibinska-Kijek A; Gruszczynska-Biegala J; Kuznicki J
    Biochim Biophys Acta; 2009 Jun; 1793(6):1050-7. PubMed ID: 19111578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.